Covista Q1 FY27 slides: enrollment growth drives guidance raise
Covista, a leading healthcare education provider, reported a decline in Q1 fiscal 2027 performance on October 29, 2026, driven by modest enrollment growth that offset a revenue increase of 10.7% to $511.5 million. Adjusted earnings per share rose 25.1% to $2.19, underscoring the company's ability to monetize enrollment expansion.
Total enrollment climbed 7.6% to 104,713 students across its nursing, medicine, veterinary medicine, and other healthcare programs. Walden University led enrollment growth, expanding 12.8% year-over-year to 58,881 students, marking the 13th consecutive quarter of growth and a record high. Revenue from Chambers University increased 7.4% to $192.4 million, while Medical & Veterinary segment enrollment grew 3.5% to 5,481 students.
Covista's strategic focus shifted to the "Purpose at Scale" phase, targeting systemically important status in U.S. healthcare education. The company returned $84 million to shareholders through share repurchases, maintaining a financially flexible position with $578 million remaining under its $750 million authorization.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
